LAM Week


Welcome to LAM Week at the ATS!

The Council of Chapter Representatives (CCR) of the ATS is happy to partner with The LAM Foundation to sponsor LAM Week at the ATS. The CCR works to enhance education about pulmonary, critical care and sleep issues, especially at local levels, and to advocate for patients, their families and healthcare providers.

Lymphangioleiomyomatosis (lim-FAN-jee-oh-ly-oh-myoh-ma-TOE-sis; LAM) is a rare lung disease that mostly affects women of childbearing age. It begins insidiously and advances to cause breathlessness first with physical activity, and later, even at rest. Thanks in part to research funded by the ATS and The LAM Foundation, much exciting progress has been made in figuring out the biologic mechanisms behind LAM, and developing specific therapy.

Most people have never heard of LAM, much less know how to pronounce its full name, and many clinicians are in the dark. The ATS recognizes the need to disseminate information publically, especially to people with LAM, their families and health care providers. The ATS, its researchers, and health professionals must interface with patients and their families. The ATS is committed to its PAR partnership with The LAM Foundation to ensure that stakeholders see the enduring value of ongoing work and research related to LAM. The LAM Foundation is an outstanding source of information and support for patients, families and friends.

Members of the ATS are international experts on LAM, and are involved in cutting edge research. Thanks to their efforts, there is the promise of improved treatment, and hopefully, an eventual cure for people with LAM.


Dona Upson, MD        
Chair , ATS Council of Chapter
Representatives (CCR)
Member, ATS Board of Directors


Jill Raleigh
Executive Director
The LAM Foundation
Member, ATS Public Advisory Roundtable

ATS LAM Partner


The LAM Foundation — a 501 (c) (3) non-profit founded in 1995 — is a global leader in the fight against lymphangioleiomyomatosis (LAM). The LAM Foundation urgently seeks safe and effective treatments, and ultimately a cure, for LAM through advocacy and the funding of promising research. The foundation is dedicated to serving the scientific, medical and patient communities by offering information, resources and a worldwide network of hope and support.


Disclaimer: "The ATS Lung Disease Week Web site is designed for educational purposes only. You should not rely on this information as a substitute for personal medical attention, a diagnosis from a physician, or direct medical care.  If you are concerned about your health or that of a family member, please consult your family's healthcare provider immediately. Do not wait for a response from our members, staff or partners."